Showing posts with label asthma. Show all posts
Showing posts with label asthma. Show all posts

Friday, March 3, 2023

Safety data of hepatitis B vaccines

The safety data on Recombivax HB, the hepatitis B vaccine for newborns, are sadly lacking, as the FDA approved the shot based on clinical trials performed on only 147 infants and children and followed for only five days
 

There are four hepatitis B vaccines, two of which are approved for infants; the second approved for infants is Engerix-B, and clinical safety data show infants and children were followed for only four days in these trials


Most infants are not at high risk for hepatitis B. It makes better financial and health sense to test mothers before birth and vaccinate only those infants born to mothers with an active or chronic hepatitis B infection, putting off vaccination in other infants until they are older
 

The current childhood vaccination schedule includes 19 potential doses of vaccines and one mRNA experimental injection by the time an infant is 6 months old. Many of these contain aluminum, which raises a child's risk of persistent asthma in childhood

Read the full analysis by Dr. Mercola

 

Subscribe to Mercola for more news & videos